'Miracle' fat-busting jabs Ozempic and Wegovy have caused 3,000 Brits to fall ill - as warning is issued over weightloss drugs loved by celebrities
The most common symptom was stomach problems but some also experienced blurred vision, depression and dizziness. Four deaths ...
WeightWatchers CEO Sima Sistani out in abrupt exit, embraced weight loss drugs
WeightWatchers announced Friday that CEO Sima Sistani is no longer at the company, and independent board member Tara Comonte ...
Novo Nordisk stock closes lower, analyst warns about Wegovy sales
Shares of Novo Nordisk (NVO) slipped on Friday following a note from JPMorgan's Richard Vosser. Vosser warned that the ...
Benefits Pro4h
Employer plans face GLP-1 anti-obesity drug rebate threats
About 40% of U.S. adults suffer from obesity, and the cost of covering GLP-1 agonists and related anti-obesity drugs can be ...
WeightWatchers CEO to Step Down After 2 Years
The company's shares have plummeted about 90 percent this year due to the rising popularity of GLP-1 drugs like Ozempic and ...
A doctor shares how his patients are trying to afford weight-loss drugs — and what happens if they can't
Drug companies are under fire for the high cost of Ozempic and simlar meds. A doctor said patients who can't afford it may ...
Almost 3,000 Brits suffer side-effects from fat-fighting jabs like Ozempic
NEARLY 3,000 Brits reported side effects from fat-fighting jabs Wegovy and Ozempic in the first 20 weeks of this year. Most had stomach problems but blurred vision, depression and dizziness have ...
Ozempic May Decrease Opioid Overdose Risk, New Research Suggests
Ozempic has been called a "wonder drug," with a growing body of research showing that it may help treat a huge range of ...
WeightWatchers CEO suddenly quits after push to embrace weight-loss drugs like Ozempic, Wegovy
Sima Sistani, who took up the CEO post at WW International two-and-a-half years ago, is out, according to the company.
Senator Bernie Sanders grills the top executive of Novo Nordisk over high drug prices
The Senate investigation showed Americans pay $1,349 a month for the weight-loss drug Wegovy, which is priced at $92 in the United Kingdom.
WeightWatchers' CEO embraced Ozempic. Now she's out of the company.
Sima Sistani helped push the company into the GLP-1 drug space with the $106 million acquisition of Sequence.
Fitness Guru Jillian Michaels Doubles Down On Warning Against Use Of Ozempic
Jillian Michaels reiterated her stance on the dangers associated with the use of Ozempic, including any health issues that ...